IL-27 and type 2 immunity in asthmatic patients: Association with severity, CXCL9, and signal transducer and activator of transcription signaling

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 2, 2015, Pages 386-394.e5

  Xie, Min ^a,b   Mustovich, Anthony T ^b   Jiang, Yi ^b   Trudeau, John B ^b   Ray, Anuradha ^b   Ray, Prabir ^b   Hu, Haizhen ^b   Holguin, Fernando ^b   Freeman, Bruce ^b   Wenzel, Sally E ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Asthma; CXCL9; epithelial cells; IL 13; IL 27; signal transducer and activator of transcription 1; signal transducer and activator of transcription 3

Indexed keywords

CXCL9 CHEMOKINE; EOTAXIN 3; INTERLEUKIN 13; INTERLEUKIN 27; MESSENGER RNA; PROTEIN; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL26 PROTEIN, HUMAN; CYTOKINE; IMMUNOGLOBULIN E; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE; TRANSCRIPTION INITIATION; WESTERN BLOTTING; YOUNG ADULT; ADOLESCENT; AGED; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CYTOLOGY; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENETICS; IMMUNITY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; RESPIRATORY TRACT MUCOSA; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; AGED; ASTHMA; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL9; CHEMOKINES, CC; CYTOKINES; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMANS; IMMUNITY; IMMUNOGLOBULIN E; INTERLEUKIN-27; MALE; MIDDLE AGED; NITRIC OXIDE; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84922385734     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.08.023     Document Type: Article

References (70)

1. P.G. Woodruff, B. Modrek, D.F. Choy, G. Jia, A.R. Abbas, and A. Ellwanger T-helper type 2-driven inflammation defines major subphenotypes of asthma Am J Respir Crit Care Med 180 2009 388 395
2. S.E. Wenzel Asthma phenotypes: the evolution from clinical to molecular approaches Nat Med 18 2012 716 725
3. J.M. Coleman, C. Naik, F. Holguin, A. Ray, P. Ray, and J.B. Trudeau Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset Thorax 67 2012 1061 1066
4. M. Yamamoto, Y. Tochino, K. Chibana, J.B. Trudeau, F. Holguin, and S.E. Wenzel Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation Clin Exp Allergy 42 2012 760 768
5. T. Owaki, M. Asakawa, N. Morishima, K. Hata, F. Fukai, and M. Matsui A role for IL-27 in early regulation of Th1 differentiation J Immunol 175 2005 2191 2200
6. J.J. Li, W. Wang, K.J. Baines, N.A. Bowden, P.M. Hansbro, and P.G. Gibson IL-27/IFN-gamma induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages J Immunol 185 2010 4401 4409
7. S. Pflanz, J.C. Timans, J. Cheung, R. Rosales, H. Kanzler, and J. Gilbert IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells Immunity 16 2002 779 790
8. C.A. Hunter New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions Nat Rev Immunol 5 2005 521 531
9. K. Nieminen, E. Valovirta, and J. Savolainen Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy Pediatr Allergy Immunol 21 2010 e174 e184
10. M. Wittmann, J. Zeitvogel, D. Wang, and T. Werfel IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes J Allergy Clin Immunol 124 2009 81 89
11. S.C. Chae, C.S. Li, K.M. Kim, J.Y. Yang, Q. Zhang, and Y.C. Lee Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population J Hum Genet 52 2007 355 361
12. Y. Cao, P.D. Doodes, T.T. Glant, and A. Finnegan IL-27 induces a Th1 immune response and susceptibility to experimental arthritis J Immunol 180 2008 922 930
13. C.A. Hunter, A. Villarino, D. Artis, and P. Scott The role of IL-27 in the development of T-cell responses during parasitic infections Immunol Rev 202 2004 106 114
14. F. Larousserie, S. Pflanz, A. Coulomb-L'Hermine, N. Brousse, R. Kastelein, and O. Devergne Expression of IL-27 in human Th1-associated granulomatous diseases J Pathol 202 2004 164 171
15. S.A. Summers, R.K. Phoon, J.D. Ooi, S.R. Holdsworth, and A.R. Kitching The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses Am J Pathol 178 2011 580 590
16. T. Yoshimoto, K. Yasuda, J. Mizuguchi, and K. Nakanishi IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation J Immunol 179 2007 4415 4423
17. C. Neufert, C. Becker, S. Wirtz, M.C. Fantini, B. Weigmann, and P.R. Galle IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 Eur J Immunol 37 2007 1809 1816
18. F. Cardinale, P. Giordano, I. Chinellato, and R. Tesse Respiratory epithelial imbalances in asthma pathophysiology Allergy Asthma Proc 34 2013 143 149
19. S.T. Holgate, D.E. Davies, S. Puddicombe, A. Richter, P. Lackie, and J. Lordan Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma Eur Respir J Suppl 44 2003 24s 29s
20. J. Cao, C.K. Wong, Y. Yin, and C.W. Lam Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-alpha: implications for immunopathophysiology of airway inflammation J Cell Physiol 223 2010 788 797
21. J. Diegelmann, T. Olszak, B. Goke, R.S. Blumberg, and S. Brand A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins J Biol Chem 287 2011 286 298
22. H.H. Ho, and L.B. Ivashkiv Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation J Biol Chem 281 2006 14111 14118
23. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986 Am Rev Respir Dis 136 1987 225 244
24. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
25. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413
26. M.L. Fajt, S.L. Gelhaus, B. Freeman, C.E. Uvalle, J.B. Trudeau, and F. Holguin Prostaglandin D2 pathway upregulation: relation to asthma severity, control, and TH2 inflammation J Allergy Clin Immunol 131 2013 1504 1512.e12
27. K. Chibana, J.B. Trudeau, A.T. Mustovich, H. Hu, J. Zhao, and S. Balzar IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells Clin Exp Allergy 38 2008 936 946
28. J. Trudeau, H. Hu, K. Chibana, H.W. Chu, J.Y. Westcott, and S.E. Wenzel Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13 J Allergy Clin Immunol 117 2006 1446 1454
29. J. Zhao, B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, and H. Hu Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells Am J Respir Crit Care Med 179 2009 782 790
30. A.J. Ravensberg, F.L. Ricciardolo, A. van Schadewijk, K.F. Rabe, P.J. Sterk, and P.S. Hiemstra Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge J Allergy Clin Immunol 115 2005 779 785
31. S. Shibata, Y. Tada, Y. Asano, K. Yanaba, M. Sugaya, and T. Kadono IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions J Invest Dermatol 133 2013 479 488
32. J. Cao, L. Zhang, D. Li, F. Xu, S. Huang, and Y. Xiang IL-27 is elevated in patients with COPD and patients with pulmonary TB and induces human bronchial epithelial cells to produce CXCL10 Chest 141 2012 121 130
33. G.D. Kalliolias, and L.B. Ivashkiv IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38 J Immunol 180 2008 6325 6333
34. S. van Wetering, S. Zuyderduyn, D.K. Ninaber, M.A. van Sterkenburg, K.F. Rabe, and P.S. Hiemstra Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13 Mol Immunol 44 2007 803 811
35. N. Voraphani, M.T. Gladwin, A.U. Contreras, N. Kaminski, J.R. Tedrow, and J. Milosevic An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma Mucosal Immunol 7 2014 1175 1185
36. W.C. Moore, D.A. Meyers, S.E. Wenzel, W.G. Teague, H. Li, and X. Li Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program Am J Respir Crit Care Med 181 2010 315 323
37. W. Wu, E. Bleecker, W. Moore, W.W. Busse, M. Castro, and K.F. Chung Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data J Allergy Clin Immunol 133 2014 1280 1288
38. H. Fujita, A. Teng, R. Nozawa, Y. Takamoto-Matsui, H. Katagiri-Matsumura, and Z. Ikezawa Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model J Immunol 183 2009 254 260
39. A.P. Freitas do Rosario, T. Lamb, P. Spence, R. Stephens, A. Lang, and A. Roers IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection J Immunol 188 2012 1178 1190
40. Z. Chen, S. Wang, N. Erekosima, Y. Li, J. Hong, and X. Qi IL-4 confers resistance to IL-27-mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling J Allergy Clin Immunol 132 2013 912 921 e1-5
41. S. Shahabuddin, R. Ji, P. Wang, E. Brailoiu, N. Dun, and Y. Yang CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways Am J Physiol Cell Physiol 291 2006 C34 C39
42. S.T. Lai, C.H. Hung, Y.M. Hua, S.H. Hsu, Y.J. Jong, and J.L. Suen T-helper 1-related chemokines in the exacerbation of childhood asthma Pediatr Int 50 2008 99 102
43. L.R. Bisset, and P. Schmid-Grendelmeier Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective Curr Opin Pulm Med 11 2005 35 42
44. L. Liu, N.N. Jarjour, W.W. Busse, and E.A. Kelly Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma Am J Respir Crit Care Med 169 2004 1118 1124
45. S. Dong, X. Zhang, Y. He, F. Xu, D. Li, and W. Xu Synergy of IL-27 and TNF-alpha in regulating CXCL10 expression in lung fibroblasts Am J Respir Cell Mol Biol 48 2013 518 530
46. C.K. Wong, P. Chen, L.S. Tam, E.K. Li, Y.B. Yin, and C.W. Lam Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis Arthritis Res Ther 12 2010 R129
47. S.K. Saha, M.A. Berry, D. Parker, S. Siddiqui, A. Morgan, and R. May Increased sputum and bronchial biopsy IL-13 expression in severe asthma J Allergy Clin Immunol 121 2008 685 691
48. M.A. Berry, D. Parker, N. Neale, L. Woodman, A. Morgan, and P. Monk Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis J Allergy Clin Immunol 114 2004 1106 1109
49. E. Piper, C. Brightling, R. Niven, C. Oh, R. Faggioni, and K. Poon A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma Eur Respir J 41 2013 330 338
50. L. Hibbert, S. Pflanz, R. De Waal Malefyt, and R.A. Kastelein IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells J Interferon Cytokine Res 23 2003 513 522
51. F. Hong, B. Jaruga, W.H. Kim, S. Radaeva, O.N. El-Assal, and Z. Tian Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS J Clin Invest 110 2002 1503 1513
52. Y. Qing, and G.R. Stark Alternative activation of STAT1 and STAT3 in response to interferon-gamma J Biol Chem 279 2004 41679 41685
53. A.P. Costa-Pereira, S. Tininini, B. Strobl, T. Alonzi, J.F. Schlaak, and H. Is'harc Mutational switch of an IL-6 response to an interferon-gamma-like response Proc Natl Acad Sci U S A 99 2002 8043 8047
54. G. Regis, S. Pensa, D. Boselli, F. Novelli, and V. Poli Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling Semin Cell Dev Biol 19 2008 351 359
55. B. Xu, A. Bhattacharjee, B. Roy, H.M. Xu, D. Anthony, and D.A. Frank Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3 Mol Cell Biol 23 2003 3918 3928
56. R. Umeshita-Suyama, R. Sugimoto, M. Akaiwa, K. Arima, B. Yu, and M. Wada Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor α chain 1: redundancy of requirement of tyrosine residue for STAT3 activation Int Immunol 12 2000 1499 1509
57. S. Wery-Zennaro, M. Letourneur, M. David, J. Bertoglio, and J. Pierre Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation FEBS Lett 464 1999 91 96
58. D.C. Newcomb, M.G. Boswell, W. Zhou, M.M. Huckabee, K. Goleniewska, and C.M. Sevin Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production J Allergy Clin Immunol 127 2011 1006 1013 e1-4
59. A.T. Peters, A. Kato, N. Zhang, D.B. Conley, L. Suh, and B. Tancowny Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps J Allergy Clin Immunol 125 2010 397 403.e10
60. K. Takeda, B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, and I. Förster Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils Immunity 10 1999 39 49
61. K. Siddiquee, S. Zhang, W.C. Guida, M.A. Blaskovich, B. Greedy, and H.R. Lawrence Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Proc Natl Acad Sci U S A 104 2007 7391 7396
62. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986 Am Rev Respir Dis 136 1987 225 244
63. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
64. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413
65. M.L. Fajt, S.L. Gelhaus, B. Freeman, C.E. Uvalle, J.B. Trudeau, and F. Holguin Prostaglandin D2 pathway upregulation: relation to asthma severity, control, and TH2 inflammation J Allergy Clin Immunol 131 2013 1504 1512.e12
66. K. Chibana, J.B. Trudeau, A.T. Mustovich, H. Hu, J. Zhao, and S. Balzar IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells Clin Exp Allergy 38 2008 936 946
67. J. Trudeau, H. Hu, K. Chibana, H.W. Chu, J.Y. Westcott, and S.E. Wenzel Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13 J Allergy Clin Immunol 117 2006 1446 1454
68. J. Zhao, B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, and H. Hu Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells Am J Respir Crit Care Med 179 2009 782 790
69. A.J. Ravensberg, F.L. Ricciardolo, A. van Schadewijk, K.F. Rabe, P.J. Sterk, and P.S. Hiemstra Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge J Allergy Clin Immunol 115 2005 779 785
70. J.M. Coleman, C. Naik, F. Holguin, A. Ray, P. Ray, and J.B. Trudeau Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset Thorax 67 2012 1061 1066